Status: current, Defined. Date: 28-Feb 2013. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 444331000036117 | Oxaliplatin PFI (Kabi) (oxaliplatin 50 mg) powder for injection, 50 mg vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 444351000036113 | Oxaliplatin PFI (Kabi) 50 mg powder for injection, 50 mg vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Oxaliplatin PFI (Kabi) 50 mg powder for injection, 50 mg vial | has Australian BoSS | oxaliplatin | true | Inferred relationship | Some | 582010080 | |
| Oxaliplatin PFI (Kabi) 50 mg powder for injection, 50 mg vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Oxaliplatin PFI (Kabi) 50 mg powder for injection, 50 mg vial | Is a | Oxaliplatin PFI (Kabi) | true | Inferred relationship | Some | ||
| Oxaliplatin PFI (Kabi) 50 mg powder for injection, 50 mg vial | Is a | oxaliplatin 50 mg injection, vial | true | Inferred relationship | Some | ||
| Oxaliplatin PFI (Kabi) 50 mg powder for injection, 50 mg vial | has manufactured dose form | powder for injection | true | Inferred relationship | Some | ||
| Oxaliplatin PFI (Kabi) 50 mg powder for injection, 50 mg vial | has unit of use | vial | true | Inferred relationship | Some | 582010081 | |
| Oxaliplatin PFI (Kabi) 50 mg powder for injection, 50 mg vial | has intended active ingredient | oxaliplatin | true | Inferred relationship | Some | 582010080 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Oxaliplatin PFI (Kabi) 50 mg powder for injection, 1 vial | has TPUU | True | Oxaliplatin PFI (Kabi) 50 mg powder for injection, 50 mg vial | Inferred relationship | Some | 1 |
| Oxaliplatin PFI (Kabi) 50 mg powder for injection, 1 vial | has TPUU | True | Oxaliplatin PFI (Kabi) 50 mg powder for injection, 50 mg vial | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR